Ensayo controlado citisina versus placebo para la cesación del tabaquismo

Ensayo controlado citisina versus placebo para la cesación del tabaquismo

Contenido principal del artículo

Claudia Zuluaga Serna, MD
Alejandra Cañas Arboleda, MD.

Descargas

Los datos de descargas todavía no están disponibles.

Detalles del artículo

Biografía del autor/a (VER)

Claudia Zuluaga Serna, MD, Pontificia Universidad Javeriana

Residente primer año Medicina Interna, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, Colombia.

Alejandra Cañas Arboleda, MD., Pontificia Universidad Javeriana

Internista, Neumóloga, Hospital Universitario San Ignacio, Profesora Asociada Pontificia Universidad Javeriana, Bogotá, Colombia.

Referencias (VER)

Alba LH, Murillo R, Becerra N, Páez N, Cañas A, Mosquera C, et al. Recomendaciones para la cesación de la adicción al tabaco en Colombia: guía de práctica clínica basada en la evidencia. Biomédica.

; 33(2) 186-204.

Ministerio de la Protección Social, Colciencias, CENDEX, S.E.I S.A. Encuesta Nacional de Salud 2007. 1ª Ed. Bogotá D.C.: Ministerio de la Protección Social; 2009.

Ministerio de Salud. II Estudio nacional de factores de riesgo de enfermedades crónicas- ENFREC II. Bogotá D.C: Ministerio de Salud; 1999.

República de Colombia. Ley 1335 de 2009. Diario Oficial No. 47.417 de 21 de julio de 2009.

Lemmens V, Oenema A, Knut IK, Bruj J. Effectiveness of smoking cessation intervention among adults: a systematic review of reviews. Eur J Cancer Preven. 2008;17:535-44. doi.org/10.1097/CEJ.0b013e3282f75e48

Fiore MC, Jaén CR, Baker TB, Bailey WC. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service;

National Institute for Health and Clinical Excellence (NICE). Brief interventions and referral for smoking cessation in primary care and other. Marzo, 2006.

Ministry of Health. New Zealand smoking cessation guidelines. Wellington: Ministry of Health; 2007.

Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007;1:CD000031.http://dx.doi.org/10.1002/14651858.CD000031

Wu P, Wilson K, Dimoulas P, Mills EJ. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006;6:300. doi.org/10.1186/1471-2458-6-300

Singh S, Loke YK, Spangler JG, Furberg CD. Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ. 2011;183:1359-66. .doi.org/10.1503/

cmaj.110218

Wagena EJ, Knipschild P, Zeegers MP. Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis. Addiction. 2005;100:317-26. doi.org/10.1111/j.1360-0443.2005.00998.x

Ministry of Health. New Zealand smoking cessation guidelines. Wellington: Ministry of Health; 2007.

Gourlay SG, Stead LF, Benowitz N. Clonidine for smoking cessation (Review). Cochrane Database Syst Rev. 2004;3:CD000058. doi.org/10.1002/14651858.CD000058.pub2

National Institute for Health and Clinical Excellence (NICE). Smoking cessation services in primary care, pharmacies, local authorities and workplaces, particularly for manual working groups, pregnant women

and hard to reach communities. London: National Institute for Health and Clinical Excellence; 2008.

Etter JF. Cytisine for smoking cessation: a literature review and a metaanalysis. Arch Intern Med. 2006;166:1553-9.

Hajek P, McRobbie H, Myers K. Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis. Thorax. 2013;68:1037-42.

Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Syst Rev. 2011;2:CD006103.

Citado por